Why the study?
Does abnormal cytology predict poor prognosis in cancer patients with pericardial effusion?
Does abnormal cytology predict poor prognosis in cancer patients with pericardial effusion?
Abnormal fluid cytology is a marker of poor survival in cancer patients with pericardial effusion, which may have important implications for clinical management.
Abnormal cytology may refine prognosis in cancer pericardial effusion; leaves open whether it should guide therapy pending prospective studies.
Malignancy is the most common cause of pericardial effusion in a tertiary care center. Cancer-related pericardial effusion is associated with adverse outcomes, and abnormal cytology further worsens prognosis. The poor survival among cancer patients with pericardial effusion and abnormal fluid cytology may have important implications for management.
No takes yet. Share an insight, caveat, or question.
Gornik et al. (2005) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: